IBD NORTHERN LTS FD TR IV

Ownership history in UBS Group AG  ·  13 quarters on record

This page tracks every 13F SEC filing in which UBS Group AG reported a position in NORTHERN LTS FD TR IV (IBD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 155 +14 +9.9% 0.00% $4K $23.74
2025 Q2 REDUCED 141 -85 -37.6% 0.00% $3K $23.36
2024 Q4 ADDED 226 +213 +1638.5% 0.00% $5K $22.34
2023 Q2 REDUCED 13 -3,141 -99.6% 0.00% $300 $20.69
2022 Q3 ADDED 3,154 +1,382 +78.0% 0.00% $71K $19.83
2021 Q3 ADDED 1,772 +1,673 +1689.9% 0.00% $46K $22.58
2020 Q4 REDUCED 99 -897 -90.1% 0.00% $3K $22.77
2020 Q3 ADDED 996 +423 +73.8% 0.00% $26K $22.45
2020 Q1 ADDED 573 +461 +411.6% 0.00% $14K $20.62
2019 Q4 REDUCED 112 -400 -78.1% 0.00% $3K $21.66
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    IBD price (monthly, adj. close)
← Back to UBS Group AG Holdings